Tadalafil Once Daily Following As-Needed Phosphodiesterase Type 5 Inhibitor Treatment, an Assessment of Return to Normal Erectile Function.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2015
At a glance
- Drugs Tadalafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.